969 related articles for article (PubMed ID: 33193999)
1. The Role of Exosomal microRNAs and Oxidative Stress in Neurodegenerative Diseases.
Wang X; Zhou Y; Gao Q; Ping D; Wang Y; Wu W; Lin X; Fang Y; Zhang J; Shao A
Oxid Med Cell Longev; 2020; 2020():3232869. PubMed ID: 33193999
[TBL] [Abstract][Full Text] [Related]
2. Potential Roles of Exosomal MicroRNAs as Diagnostic Biomarkers and Therapeutic Application in Alzheimer's Disease.
Chen JJ; Zhao B; Zhao J; Li S
Neural Plast; 2017; 2017():7027380. PubMed ID: 28770113
[TBL] [Abstract][Full Text] [Related]
3. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
[TBL] [Abstract][Full Text] [Related]
4. Role of Exosomal MicroRNAs and Their Crosstalk with Oxidative Stress in the Pathogenesis of Osteoporosis.
Lu J; Zhang Y; Liang J; Diao J; Liu P; Zhao H
Oxid Med Cell Longev; 2021; 2021():6301433. PubMed ID: 34336108
[TBL] [Abstract][Full Text] [Related]
5. Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease.
Van Giau V; An SS
J Neurol Sci; 2016 Jan; 360():141-52. PubMed ID: 26723991
[TBL] [Abstract][Full Text] [Related]
6. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
[TBL] [Abstract][Full Text] [Related]
7. Exosomal microRNAs as diagnostic biomarkers and therapeutic applications in neurodegenerative diseases.
Sataer X; Qifeng Z; Yingying Z; Chunhua H; Bingzhenga F; Zhiran X; Wanli L; Yuwei Y; Shuangfeng C; Lingling W; Hongri H; Jibing C; Xiaoping R; Hongjun G
Neurol Res; 2023 Mar; 45(3):191-199. PubMed ID: 36184105
[TBL] [Abstract][Full Text] [Related]
8. The role of exosomal microRNAs in central nervous system diseases.
Yu Y; Hou K; Ji T; Wang X; Liu Y; Zheng Y; Xu J; Hou Y; Chi G
Mol Cell Biochem; 2021 May; 476(5):2111-2124. PubMed ID: 33528706
[TBL] [Abstract][Full Text] [Related]
9. Neuronal exosomal miRNAs modulate mitochondrial functions and cell death in bystander neuronal cells under Parkinson's disease stress conditions.
Currim F; Shukla S; Singh J; Gohel D; Mane M; Shinde A; Roy M; Goyani S; Vasiyani H; Chandran A; Rochet JC; Cannon J; Singh R
Neurotoxicology; 2024 Mar; 101():102-116. PubMed ID: 38401688
[TBL] [Abstract][Full Text] [Related]
10. Environmental neurotoxicant manganese regulates exosome-mediated extracellular miRNAs in cell culture model of Parkinson's disease: Relevance to α-synuclein misfolding in metal neurotoxicity.
Harischandra DS; Ghaisas S; Rokad D; Zamanian M; Jin H; Anantharam V; Kimber M; Kanthasamy A; Kanthasamy AG
Neurotoxicology; 2018 Jan; 64():267-277. PubMed ID: 28450057
[TBL] [Abstract][Full Text] [Related]
11. Effects of exosomal miRNAs in the diagnosis and treatment of Alzheimer's disease.
Cui GH; Zhu J; Wang YC; Wu J; Liu JR; Guo HD
Mech Ageing Dev; 2021 Dec; 200():111593. PubMed ID: 34756925
[TBL] [Abstract][Full Text] [Related]
12. Exosomes in Pathogenesis, Diagnosis, and Treatment of Alzheimer's Disease.
Jiang L; Dong H; Cao H; Ji X; Luan S; Liu J
Med Sci Monit; 2019 May; 25():3329-3335. PubMed ID: 31056537
[TBL] [Abstract][Full Text] [Related]
13. Exosome-encapsulated microRNAs as promising biomarkers for Alzheimer's disease.
Chen JJ; Yang G; Yan QQ; Zhao J; Li S
Rev Neurosci; 2019 Dec; 31(1):77-87. PubMed ID: 31318699
[TBL] [Abstract][Full Text] [Related]
14. Serum secreted miR-137-containing exosomes affects oxidative stress of neurons by regulating OXR1 in Parkinson's disease.
Jiang Y; Liu J; Chen L; Jin Y; Zhang G; Lin Z; Du S; Fu Z; Chen T; Qin Y; Sun X
Brain Res; 2019 Nov; 1722():146331. PubMed ID: 31301273
[TBL] [Abstract][Full Text] [Related]
15. Exosomal microRNAs as diagnostic and therapeutic biomarkers in non-malignant liver diseases.
Hwang S; Yang YM
Arch Pharm Res; 2021 Jun; 44(6):574-587. PubMed ID: 34165701
[TBL] [Abstract][Full Text] [Related]
16. Exosomal microRNAs in the development of essential hypertension and its potential as biomarkers.
Tan PPS; Hall D; Chilian WM; Chia YC; Mohd Zain S; Lim HM; Kumar DN; Ching SM; Low TY; Md Noh MF; Pung YF
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1486-H1497. PubMed ID: 33577433
[TBL] [Abstract][Full Text] [Related]
17. Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents.
Xia X; Wang Y; Huang Y; Zhang H; Lu H; Zheng JC
Prog Neurobiol; 2019 Dec; 183():101694. PubMed ID: 31542363
[TBL] [Abstract][Full Text] [Related]
18. Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer's Disease.
Manna I; De Benedittis S; Quattrone A; Maisano D; Iaccino E; Quattrone A
Pharmaceuticals (Basel); 2020 Sep; 13(9):. PubMed ID: 32932746
[TBL] [Abstract][Full Text] [Related]
19. [Free radical processes in aging, neurodegenerative diseases and other pathological states].
Dubinina EE; Pustygina AV
Biomed Khim; 2007; 53(4):351-72. PubMed ID: 18035718
[TBL] [Abstract][Full Text] [Related]
20. The Role of Exosomes in Stemness and Neurodegenerative Diseases-Chemoresistant-Cancer Therapeutics and Phytochemicals.
Beeraka NM; Doreswamy SH; Sadhu SP; Srinivasan A; Pragada RR; Madhunapantula SV; Aliev G
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
